当前位置: X-MOL 学术Bioconjugate Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
Bioconjugate Chemistry ( IF 4.0 ) Pub Date : 1993-11-01 , DOI: 10.1021/bc00024a015
D Willner 1 , P A Trail , S J Hofstead , H D King , S J Lasch , G R Braslawsky , R S Greenfield , T Kaneko , R A Firestone
Affiliation  

The (6-maleimidocaproyl)hydrazone of doxorubicin was synthesized and conjugated to several mAbs, including chimeric BR96, via a Michael addition reaction to thiol-containing mAbs. DTT reduction of disulfides present in the mAb was a reliable and general method for generating a consistent number of reactive SH groups. The conjugates, after purification by Bio-Beads, were free of unreacted linker and/or doxorubicin. All conjugates released doxorubicin under acidic conditions that mimic the lysosomal environment, while they were relatively stable at neutral pH. BR96 conjugates showed antigen-specific cytotoxicity.

中文翻译:

阿霉素的(6-Maleimidocaproyl)--一种制备阿霉素免疫缀合物的新衍生物。

合成了阿霉素的(6-马来酰亚胺基己酰基)hydr,并通过与含硫醇的mAb进行迈克尔加成反应将其与几种mAb(包括嵌合BR96)偶联。DTT还原mAb中存在的二硫键是一种可靠且通用的方法,用于生成一致数量的反应性SH基团。在通过Bio-Beads纯化后,偶联物不含未反应的接头和/或阿霉素。所有缀合物在模拟溶酶体环境的酸性条件下释放阿霉素,而它们在中性pH下相对稳定。BR96偶联物显示出抗原特异性细胞毒性。
更新日期:2019-11-01
down
wechat
bug